date:Aug 18, 2012
under its Seven Seas in many European countries.
This Merck rejection follows a 2009 article 13.1 general function opinion that glucosamine does not benefit the normal function of joints, either alone or in conjunction with typical food supplement stable mate, chondroitin.
61 references
We are disappointed upon receiving a negative opinion on the health claim submission for glucosamine,said Dr Udit Batra, head of Consumer Health at Merck.
We strongly believe in the benefits of glucosamine o